P
Philip D. Anderson
Researcher at Harvard University
Publications - 36
Citations - 1375
Philip D. Anderson is an academic researcher from Harvard University. The author has contributed to research in topics: Emergency department & Health care. The author has an hindex of 15, co-authored 36 publications receiving 1198 citations. Previous affiliations of Philip D. Anderson include Brigham and Women's Hospital & Pennsylvania State University.
Papers
More filters
Journal ArticleDOI
International perspectives on emergency department crowding.
Jesse M. Pines,Joshua A. Hilton,Ellen J. Weber,A.J. Alkemade,Hasan Al Shabanah,Philip D. Anderson,Michael Bernhard,Alessio Bertini,André Gries,Santiago Ferrandiz,Vijaya Arun Kumar,Veli-Pekka Harjola,Barbara Hogan,Bo Madsen,Suzanne Mason,Gunnar Öhlén,Timothy H. Rainer,Niels K. Rathlev,Eric Revue,Drew B Richardson,M. Sattarian,Michael J. Schull +21 more
TL;DR: In this article, the authors describe emergency care systems and the extent of crowding across 15 countries outside of the United States: Australia, Canada, Denmark, Finland, France, Germany, Hong Kong, India, Iran, Italy, The Netherlands, Saudi Arabia, Catalonia (Spain), Sweden, and the United Kingdom.
Journal ArticleDOI
Isolation of Epiblast Stem Cells from Preimplantation Mouse Embryos
Fadi J. Najm,Josh G. Chenoweth,Philip D. Anderson,Joseph H. Nadeau,Raymond W. Redline,Ronald D.G. McKay,Paul J. Tesar +6 more
TL;DR: It is shown that mouse embryonic stem (ES) cells and epiblast stem cells (EpiSCs) are distinct, pluripotent states isolated from pre- and post-implantation embryos respectively.
Journal ArticleDOI
World Health Assembly Resolution 60.22 and Its Importance as a Health Care Policy Tool for Improving Emergency Care Access and Availability Globally
Philip D. Anderson,Robert E. Suter,Terrence Mulligan,Terrence Mulligan,Gautam Bodiwala,Junaid Abdul Razzak,Charles Mock +6 more
TL;DR: This resolution represents a unique opportunity for emergency care providers and other advocates for improved emergency care to engage with national and local health care officials and policymakers, as well as with the World Health Organization, to make substantial improvements in emergency care delivery in places where it is most needed.
Journal ArticleDOI
PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer
Austin N. Kirschner,Jie Wang,Riet van der Meer,Philip D. Anderson,Omar E. Franco-Coronel,Max H. Kushner,Joel H. Everett,Omar Hameed,Erika K. Keeton,Miika Ahdesmaki,Shaun E. Grosskurth,Dennis Huszar,Sarki A. Abdulkadir +12 more
TL;DR: PIM inhibition is a potential treatment for MYC-driven prostate cancers including CRPC, and its effectiveness may be enhanced by activators of the p53 pathway, such as radiation.
Journal ArticleDOI
NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
Magdalena M. Grabowska,Amicia D. Elliott,David J. DeGraff,Philip D. Anderson,Govindaraj Anumanthan,Hironobu Yamashita,Qian Sun,David B. Friedman,David L. Hachey,Xiuping Yu,Jonathan H. Sheehan,Jung-Mo Ahn,Ganesh V. Raj,David W. Piston,Richard M. Gronostajski,Robert J. Matusik +15 more
TL;DR: Observations suggest that NFI regulation of FOXA1/AR action is a frequent event, with individual family members playing distinct roles in AR target gene expression.